Patients with CFLD undergoing initial assessment for liver transplantation may benefit from consideration of simultaneous liver-pancreas transplantation.
Aims/hypothesis. Leptin-deficient ob/ob mice are hyperinsulinaemic and hyperglycaemic; however, the cause of hyperglycaemia remains largely unknown. Methods. Glucose metabolism in vivo in 9-h fasted ob/ob mice and lean littermates was studied by infusing [U-13 C]-glucose, [2-13 C]-glycerol, [1-2 H]-galactose and paracetamol for 6 h, applying mass isotopomer distribution analysis on blood glucose and urinary paracetamol-glucuronide. Results. When expressed on the basis of body weight, endogenous glucose production (109±23 vs 152±27 µmol·kg -1 ·min -1 , obese versus lean mice, p<0.01) and de novo synthesis of glucose-6-phosphate (122±13 vs 160±6 µmol·kg -1 ·min -1 , obese versus lean mice, p<0.001) were lower in ob/ob mice than in lean littermates. In contrast, glucose cycling was greatly increased in obese mice (56±13 vs 26±4 µmol·kg -1 ·min -1 , obese versus lean mice, p<0.001). As a result, total hepatic glucose output remained unaffected (165±31 vs 178±28 µmol·kg -1 ·min -1 , obese vs lean mice, NS). The metabolic clearance rate of glucose was significantly lower in obese mice (8±2 vs 18±2 ml·kg -1 ·min -1 , obese versus lean mice, p<0.001). Hepatic mRNA levels of genes encoding for glucokinase and pyruvate kinase were markedly increased in ob/ob mice. Conclusions/interpretation. Unaffected total hepatic glucose output in the presence of hyperinsulinaemia reflects hepatic insulin resistance in ob/ob mice, which is associated with markedly increased rates of glucose cycling. Hyperglycaemia in ob/ob mice primarily results from a decreased metabolic clearance rate of glucose.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.